Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,778 across all filing types
Latest filing 2013-10-28 Investor Presentation
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Investor Presentation 2013
Investor Presentation Classification · 98% confidence The document contains a detailed financial analysis, including a recommendation (BUY), price target updates, historical financial tables (Y/E 31.12.), contact information for research staff, and extensive disclaimers regarding conflicts of interest under German Securities Trading Act (§ 34b WpHG). This structure is characteristic of an independent equity research report or investment analysis, which is best classified as an Investor Presentation (IP) or a general research document. Since 'Investor Presentation' (IP) is defined as a detailed presentation focusing on financials, strategy, and market position, and this document clearly fits the profile of a published equity research note providing analysis and forecasts, IP is the most appropriate category. It is not a formal regulatory filing like a 10-K or an Earnings Release (ER) which typically only contains the company's official results announcement.
2013-10-28 English
Declaration of Voting Results & Voting Rights Announcements 2013
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details the crossing of a voting rights threshold (5%) by Morgan Stanley concerning Evotec AG, citing Article 26, Section 1 of the WpHG (German Securities Trading Act). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes or related announcements like voting rights changes.
2013-10-25 English
Declaration of Voting Results & Voting Rights Announcements 2013
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states 'Voting Rights Announcements' in the header and details a notification pursuant to 'sec. 25 WpHG' regarding the crossing of a voting rights threshold by Morgan Stanley Capital Management LLC. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes or related announcements like changes in significant ownership thresholds.
2013-10-25 English
Declaration of Voting Results & Voting Rights Announcements 2013
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and references German Securities Trading Act (WpHG) sections related to voting rights notifications. It details a notification received from Morgan Stanley Domestic Holdings Inc. regarding crossing a voting rights threshold (5%) in Evotec AG. This directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). Although it is a regulatory notification, DVA is a more specific category than the general RNS.
2013-10-25 English
Declaration of Voting Results & Voting Rights Announcements 2013
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details the crossing of a voting rights threshold (5%) by Morgan Stanley & Co. LLC in Evotec AG, citing Article 26, Section 1 of the WpHG (German Securities Trading Act). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes and related announcements like changes in significant share ownership thresholds.
2013-10-25 English
Declaration of Voting Results & Voting Rights Announcements 2013
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details the crossing of a voting rights threshold (5%) by Morgan Stanley in Evotec AG, citing German Securities Trading Act (WpHG) articles (Art. 26, Section 1 and Art. 25a, Sec. 1). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes or related notifications like changes in significant share ownership thresholds.
2013-10-25 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.